New Mouse Models of Retinal Degeneration Enable Transplantation of Retinal Sheets Derived from Human Embryonic Stem Cells

Wednesday, May 16, 2018 Genetics & Stem Cells News
Email Print This Page Comment bookmark
Font : A-A+

KAWASAKI, Japan, May 16, 2018 /PRNewswire/ --

Researchers affiliated with the Kawasaki INnovation Gateway at SKYFRONT,

have developed new mouse models of retinal degeneration enable transplantation of retinal sheets derived from human embryonic stem cells. These results are reported in the journal Stem Cell Reports and show their approach to be promising for the
treatment of retina degeneration by transplanting retinal tissue derived from embryonic or induced pluripotent stem cells.

     (Photo: https://mma.prnewswire.com/media/692329/Skyfront_Fig1.jpg )

Further information about science and technology projects at Kawasaki City is available in the Kawasaki SkyFront iNewsletter that highlights research being conducted by scientists and industries affiliated with Kawasaki INnovation Gateway at SKYFRONT (KING SKYFRONT )-the City's flagship science and technology hub launched in 2013 to focus on open innovation in the life sciences and environment.

May 2018 issue of Kawasaki SkyFront iNewsletter

http://inewsletter-king-skyfront.jp/en/

New mouse models of retinal degeneration enable transplantation of retinal sheets derived from human embryonic stem cells  

http://inewsletter-king-skyfront.jp/en/research_highlights/vol-12-research01/

Retinal degeneration, a pathology in which the cells in the retina progressively die, leads to impaired vision and, in some cases, blindness. A promising therapeutic option for the treatment of retina degeneration consists of transplanting retinal tissue derived from embryonic or induced pluripotent stem cells (ES/IPS cells).

It is known that photoreceptor precursor cells derived from embryonic stem cells can be transplanted in adult mouse models of retinal degeneration that still have dysfunctional photoreceptor layer (or outer nuclear layer). In these models, the transplanted photoreceptor cells restored some vision, but it was recently considered due to transfer of materials from the transplanted cells to remaining dysfunctional cells. On the other hand, it has also been shown that the transplanted retinal sheets differentiated from mouse ES or iPS cells can create new synaptic connections and partially restore vision even in models of end-stage retinal degeneration in which there is no functioning photoreceptor layer. However, transplanting retina sheets derived from human embryonic stem cells in rodent models is challenging and often results in rejection and in the transplanted cells not maturing properly.

Thus, immunodeficient end-stage retinal degeneration mouse models without any outer nuclear layer structure are important for preclinical studies investigating the feasibility of transplantation of tissues derived from human embryonic stem cells or induced pluripotent stem cells. In a study just published in Stem Cell Reports by Motohito Goto, Central Institute for Experimental Animals, Animal Resources and Technical Research Center, Kawasaki, Japan, and colleagues, two mouse models developed using marker-assisted breeding are presented and characterized. In the two models, the photoreceptor degeneration proceeds at different speed.

The researchers transplanted retinal sheets derived from human embryonic stem cells in one of the models, characterized the structure of the transplanted retina and of the host-graft interface and measured the response to light. The retinal sheets were integrated for a long period of time, and showed signs of photoreceptor maturation, including the formation of light-responsive inner/outer segments and of synapses. A full-field electroretinography response was not detected (this measures the electrical responses of various cell types in the retina, including the photoreceptors, inner retinal cells, and the ganglion cells), but this does not necessarily imply total blindness. By contrast, retinal ganglion cell responses to light stimuli were observed in 3 transplanted retinas out of 7 that were measured. Thus, there was some indication of a functional integration of the transplanted tissues with the host retina, even though less successful than with mouse-derived stem cells in these mice models.

As the authors conclude, "this study supports the use of these animals in preclinical studies, as well as the competency of human embryonic stem cell retina for future clinical applications in retinitis pigmentosa patients".

Publication and Affiliations 

Satoshi Iraha,1,2,3,10 Hung-Ya Tu,1,10 Suguru Yamasaki,1,4 Takahiro Kagawa,5 Motohito Goto,5

Riichi Takahashi,5 Takehito Watanabe,1 Sunao Sugita,1 Shigenobu Yonemura,6,7 Genshiro A. Sunagawa,1 Take Matsuyama,1 Momo Fujii,1 Atsushi Kuwahara,4 Akiyoshi Kishino,4 Naoshi Koide,1 Mototsugu Eiraku,8 Hidenobu Tanihara,2 Masayo Takahashi,1,3 and Michiko Mandai1,9,*, Establishment of Immunodeficient Retinal Degeneration Model Mice and Functional Maturation of Human ESC-Derived Retinal Sheets after Transplantation, Stem Cell Reports (2018).

https://doi.org/10.1016/j.stemcr.2018.01.032

  1. Laboratory for Retinal Regeneration, Center for Developmental Biology, RIKEN, Kobe, Hyogo 650-0047, Japan
  2. Department of Ophthalmology, Faculty of Life Sciences, Kumamoto University, Kumamoto 860-8556, Japan
  3. Application Biology and Regenerative Medicine, Graduate School of Medicine, Kyoto University, Kyoto 606-8501, Japan
  4. Regenerative and Cellular Medicine Office, Sumitomo Dainippon Pharma Co., Ltd., Kobe, Hyogo 650-0047, Japan
  5. Central Institute for Experimental Animals, Animal Resources and Technical Research Center, Kawasaki, Kanagawa 210-0821, Japan
  6. Ultrastructural Research Team, RIKEN Center for Life Science Technologies., Kobe, Hyogo 650-0047, Japan
  7. Department of Cell Biology, Tokushima University Graduate School of Medical Science, Tokushima 770-8503, Japan
  8. Laboratory for in vitro Histogenesis, RIKEN Center for Developmental Biology, Kobe, Hyogo 650-0047, Japan
  9. RIKEN Program for Drug Discovery and Medical Technology Platforms (DMP), Kobe, Hyogo 650-0047, Japan
  10. Co-first author

About KING SKYFRONT 

KING SKYFRONT is located on the opposite side of the Tama River that separates Tokyo International Airport (also known as Haneda Airport) and the Tonomachi district of Kawasaki. The Airport plays an important role in the globalization of the innovative activities of scholars, industrialists and City administrators based at KING SKYFRONT.

KING SKYFRONT was launched in 2013 as a base for scholars, industrialists and government administrators to work together to devise real life solutions to global issues in the life sciences and environment.

Further information: Mr R. Naekura Kawasaki City, Japan, Coastal Area International Strategy Office General Planning Bureau, City of Kawasaki, 1 Miyamoto-cho, Kawasaki-ku, Kawasaki-city, Kanagawa 210-8577 Japan EMAIL: 20rinkai@city.kawasaki.jp TEL: +81-(0)-44-200-3634

http://www.city.kawasaki.jp/en/category/132-5-0-0-0-0-0-0-0-0.html

SOURCE KING SKYFRONT

Advertisement


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store